Physics and imaging in radiation oncology · 2026
Quality assurance of online adaptive radiotherapy workflows using film dosimetry in a 3D printed thorax anthropomorphic phantom.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hoffmans Daan, Nelissen Koen, Versteijne Eva, Verbakel Wilko
Аннотация
BACKGROUND AND PURPOSE: Quality Assurance for online adaptive radiotherapy (oART) can be challenging. Several tests can demonstrate the dosimetric and position accuracy, but commercial phantoms are often not anatomically representative. The aim of this study was to investigate the accuracy of cone-beam computed tomography guided oART palliative and breast cancer trials by using a 3D printed thorax anthropomorphic phantom.
MATERIALS AND METHODS: An anthropomorphic phantom was 3D printed for this study which accommodates film through the spine, breast, heart, and lungs. Dose was measured for spine and breast treatment plans, whilst variations were simulated which can occur during treatment. Measurements were compared to calculated dose on the planning (pCT) and synthetic computed tomography (sCT) using gamma pass rate criteria of minimal 95 % (for gamma of 4 %/2 mm). Differences between the mean gamma were tested for significance.
RESULTS: Measurements done with positional and target volume changes showed no significant difference between the gamma analyses for the pCT and sCT (p = 0.15), indicating a robust and safe workflow. For extreme variations, difference was found between gamma analyses for the pCT and sCT (p = 0.051). Pass rates were all >95 %, except for three measurements in which the sCT showed density errors up to 1000 Hounsfield Units.
CONCLUSIONS: This QA approach for oART, which used film measurements in a custom 3D-printed anthropomorphic phantom was able to validate the accuracy of the oART workflow when anatomical deviations arise and could be suitable as end-to-end test in the future.
MATERIALS AND METHODS: An anthropomorphic phantom was 3D printed for this study which accommodates film through the spine, breast, heart, and lungs. Dose was measured for spine and breast treatment plans, whilst variations were simulated which can occur during treatment. Measurements were compared to calculated dose on the planning (pCT) and synthetic computed tomography (sCT) using gamma pass rate criteria of minimal 95 % (for gamma of 4 %/2 mm). Differences between the mean gamma were tested for significance.
RESULTS: Measurements done with positional and target volume changes showed no significant difference between the gamma analyses for the pCT and sCT (p = 0.15), indicating a robust and safe workflow. For extreme variations, difference was found between gamma analyses for the pCT and sCT (p = 0.051). Pass rates were all >95 %, except for three measurements in which the sCT showed density errors up to 1000 Hounsfield Units.
CONCLUSIONS: This QA approach for oART, which used film measurements in a custom 3D-printed anthropomorphic phantom was able to validate the accuracy of the oART workflow when anatomical deviations arise and could be suitable as end-to-end test in the future.